Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News & Events

September 16, 2025

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)

Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard...

August 21, 2025

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

This investment marks BrainsWay’s entrance into the market for mental health therapies that can be...

August 20, 2025

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S....

August 13, 2025

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating...

July 31, 2025

BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental Health Professionals

BURLINGTON, Mass. and JERUSALEM, Israel, July 30, 2025 (GLOBE NEWSWIRE) — BrainsWay, a global...

July 30, 2025

BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025

BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025 Download PDF BURLINGTON,...

July 17, 2025

Medscape CME Course: Data-Driven Insights for Incorporating Transcranial Magnetic Stimulation Into Your Practice

Data-Driven Insights for Incorporating Transcranial Magnetic Stimulation Into Your Practice Discover...

June 11, 2025

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Improvement in depression scores, response and remission were all found to be comparable with standard...

June 10, 2025

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Deep TMS Takes Center Stage with Compelling Research BURLINGTON, Mass. and JERUSALEM, June 10, 2025...

June 4, 2025

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

BrainsWay is actively evaluating similar investments in other leading U.S. mental health providers to...

May 13, 2025

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

Achieved record quarterly sales of $11.5 million in Q1 2025, an increase of 27% compared to Q1 2024 Operating...

May 2, 2025

BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles

Exhibit Booth Demonstrations and Participation in Expert Master Course Highlight BrainsWay’s Expanding...

March 11, 2025

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full...

March 4, 2025

BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

BURLINGTON, Mass. and JERUSALEM, March 04, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

February 24, 2025

BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

BURLINGTON, Mass. and JERUSALEM, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ...

December 12, 2024

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Israel, December 12, 2024 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

November 19, 2024

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Reductions also seen in comorbid anxiety and depression symptoms BURLINGTON, Mass. and JERUSALEM, Israel,...

November 12, 2024

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41...